Needle-less to say, it’s effective! Eli Lilly’s experimental GLP-1 pill caused participants in a late-stage trial to shed an average of 10.5% of their body weight — nearly 23 pounds — over 16 months, ...

Eli Lilly LLY1.57%increase; green up pointing triangle said a third late-stage study of its experimental anti-obesity pill hit its key goals, paving the way for the drugmaker to begin regulatory ...

The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to request global regulatory approval this year, the company said Tuesday. The only ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Eli Lilly’s ...

Eli Lilly says its experimental GLP-1 pill helped overweight adults with Type 2 diabetes shed 10.5% of body weight in a late-stage trial, after recent data from another study of the drug in patients ...

Following the four-color glow at the start of this month, the Gemini overlay is now a pill with a rather gooey launch animation. The Gemini overlay you launch with the “Hey Google” hotword, ...

Aug 19 (Reuters) - Viking Therapeutics (VKTX.O), opens new tab said Tuesday its experimental weight-loss pill helped patients lose 12.2% of their body weight in a mid-stage trial, missing Wall ...

A Viking Therapeutics drug that hits two targets to spark weight loss achieved the goals of a closely watched mid-stage clinical trial, but with results that also show many patients stopped the ...

Shares of Viking Therapeutics plummeted more than 43% Tuesday after the company revealed poorer-than-expected mid-stage trial data for its experimental weight-loss pill, joining Eli Lilly with similar ...

Viking Therapeutics Inc. plunged in early trading on Tuesday after its experimental obesity pill disappointed in a mid-stage study, marking another weaker-than-expected result for an oral alternative ...

Mumbai, Aug 19, 2025 (ANI): "Faltu hain ekdum…” Passengers describe horror inside Mumbai Monorail breakdown | Rescue underway Trump's claim on India falls flat: US embassy denies $21 million USAID ...

Aging is the strongest risk factor for most chronic diseases; however, medicine has historically treated each condition individually. Geroscience is a new discipline that aims to define and modify ...